Oncoinvent ASA (LON:0RU5)
London · Delayed Price · Currency is GBP · Price in NOK 42.50
-0.06 (-0.13%)
Feb 10, 2026, 11:47 AM GMT
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 14.83 million as of February 12, 2026.
Market Cap
14.83M
Enterprise Value
9.50M
Revenue
1.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.50
Market Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 14.11M to 14.83M, an increase of 5.08%. That is a compound annual growth rate of 19.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 15.01M | -7.67% |
| Dec 30, 2025 | 16.26M | 15.24% |
| Oct 30, 2025 | 14.11M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| Fusion Antibodies | 19.38M |
| Renalytix | 18.03M |
| Cambridge Cognition Holdings | 16.54M |
| Inspiration Healthcare Group | 15.47M |